Purpose: Artificial intelligence (AI) technology is poised to revolutionise the way we deliver healthcare. We set to evaluate the patient perspective of AI use in their diabetic eye screening. Methods: Two-hundred and one patients undergoing diabetic retinal screening across three centres in Auckland participated in a survey about their opinion regarding the use of AI technology in their eye screening. The survey collected consisted of 17 questions covering topics of AI awareness, trust in AI systems, perceived benefits and receptivity towards AI systems. Results: There was an equal distribution of males to females. The mean age was 57 years (range 18 - 90). The majority of participants identified as New Zealand European (44), followed by Asian (39), Pacific Islander (10) and Maori (5). While 66 of participants were aware of AI, only 49 have heard it was being implemented in healthcare. Overall, 70 of respondents were comfortable with AI use in their care, with 49 saying they would trust an AI-assisted screening program as much as a health professional. The main perceived benefits of AI included faster diagnostic speeds and greater accuracy. Almost all respondents stated they would trust AI more with doctor supervision. Conclusion: There is a low awareness of AI among our participants and wider public. Despite this, most are receptive towards the implementation of AI in diabetic eye screening. Overall, there was a strong preference towards continual involvement of clinicians in the screening process.
展开▼
